Developer docs
API playgroundTry for free, no card

Search company profiles

Diagnostics Research Group

Full company profile

uuid0007trv

Namestring
Diagnostics Research Group
Legal namestring
IMA Clinical Research Inc.
Websiteurl
dxrg.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

IMA Clinical Research Inc., doing business as Diagnostics Research Group and IMA Clinical Research, is a US-based clinical trial site network founded in 2000 and headquartered in Tarrytown, New York. The company operates 15+ satellite clinical trial sites across 10 states supported by 150+ full-service site locations, with a 400K+ patient database and 10K+ unique weekly patient visits. It runs site-based, hybrid, and fully decentralized clinical trials across four core therapeutic areas: depression, obesity, metabolic liver disease (MASH/NASH), and memory loss.

The platform's underlying technology is operational rather than software-centric: flexible patient outreach centers that can be deployed wherever and whenever needed, patient-centric technology supporting remote participation, and a large proprietary patient database enabling efficient enrollment of qualified, diverse participants. The company offers free liver scans and participant compensation for time and travel as patient-side recruitment tools.

Revenue is generated through professional services contracts with pharmaceutical sponsors and Contract Research Organizations (CROs), structured as per-enrolled-participant compensation with additional payments for specific trial milestones and procedures. The company sells to two customer segments: pharmaceutical sponsors and CROs (the primary enterprise revenue source) and patients (a recruitment channel, not a revenue stream). Go-to-market combines direct enterprise field sales with sponsor-facing thought leadership (webinars, ACRP conference participation, knowledge center content) and patient-facing community outreach (referral programs, social media, phone-based outreach centers).

Short descriptiontext

IMA Clinical Research (Diagnostics Research Group) is a US-based clinical trial site network operating 15+ satellite sites across 10 states with a 400K+ patient database, providing site-based, hybrid, and decentralized trial services to pharmaceutical sponsors and CROs across therapeutic areas including depression, obesity, MASH, and memory loss.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Antonio, United States
HQ citystring
San Antonio
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices15 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, site-based trials, decentralized clinical trials, patient recruitment, therapeutic research
Industry1 code
PRIMARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Clinical Research Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services Contracts
TypeProfessional Services
Description

Revenue generated through contracts with pharmaceutical sponsors and Contract Research Organizations (CROs) for conducting clinical trials. Compensation is provided for each enrolled participant, with additional payments for specific trial milestones and procedures performed.

imaresearch.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Diagnostics Research Group operates the IMA Clinical Research Network, a flexible clinical trial network that conducts site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs across multiple therapeutic areas including depression, obesity, MASH (metabolic liver disease), and memory loss. The network spans 15+ satellite sites and 150+ total locations in the U.S., supported by a 400K+ patient database with 10K+ unique weekly visits and deployable patient outreach centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 400K+ patient database with 10K+ unique weekly visits
+1 more record
Product overview1 text field

IMA Clinical Research operates a flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials. The network includes full-service clinical trial sites and 15+ nationwide satellite sites with over 10,000 unique weekly visits and access to 400K+ patient database. The platform provides patient-centric technology supporting flexible trial models with deployable patient outreach centers. Therapeutic areas include depression, obesity, liver/MASH, and memory loss clinical trials.

Product and service9 records
1IMA Clinical Research Network
CategoryCore network offering
Description

Flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs, comprising full-service sites and 15+ nationwide satellite sites with access to a 400K+ patient database.

2Site-Based Clinical Trials
CategoryService offering
Description

Traditional in-person clinical trial conduct at full-service clinical trial sites located across multiple states including Arizona, Florida, Illinois, Louisiana, North Carolina, New Jersey, New Mexico, Nevada, New York, and Texas.

3Hybrid Clinical Trials
CategoryService offering
Description

Combination of site-based and remote participation options, allowing flexible trial conduct with patient outreach centers set up wherever and whenever needed.

4Fully Decentralized Clinical Trials
CategoryService offering
Description

Remote clinical trial participation options enabled through patient-centric technology, reaching patients regardless of geographic location.

5Patient Outreach Centers
CategoryService offering
Description

Flexible patient outreach centers deployed wherever and whenever needed to support clinical trial recruitment and expand access to participants across the United States.

6Depression Clinical Trials
CategoryTherapeutic area trial program
Description

Clinical trials for depression currently enrolling patients in Hickory NC, Monroe LA, Albuquerque NM, Phoenix AZ, and Las Vegas NV, with compensation offered to participants for time and travel.

7Obesity Clinical Trials
CategoryTherapeutic area trial program
Description

Clinical trials for obesity enrolling in Warren NJ, St. Petersburg FL, Austin TX, San Antonio TX, Lenoir NC, and Monroe LA, with compensation offered for time and travel.

8Liver/MASH Clinical Trials
CategoryTherapeutic area trial program
Description

Clinical trials for metabolic-associated steatohepatitis (MASH) with free liver scans for individuals with BMI over 27, enrolling in Austin TX, San Antonio TX, Warren NJ, New York City NY, and Westchester NY.

9Memory Loss Clinical Trials
CategoryTherapeutic area trial program
Description

Clinical trials for memory loss enrolling adults 55 and older with compensation offered for time and travel, currently enrolling in Albuquerque NM and San Antonio TX.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Professional association for clinical research professionals. IMA Clinical Research staff actively participate in ACRP events and conferences (e.g., ACRP 2026), demonstrating ongoing professional relationship and industry engagement.

2AMRC (Albuquerque Medical Research Center)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AMRC is listed as an affiliated organization, with the Albuquerque Neurosciences site operating under this partnership. Represents strategic alignment in the clinical research network.

imaresearch.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

National multi-therapeutic clinical trial site network offering site-based, hybrid, and DCT options to sponsors/CROs; directly comparable to IMA in model, therapeutic areas, and customer base.

TypeDirect peer
Description

Multi-site SMO focused on specialty Phase 2–4 trials in CNS, metabolic, pain, and other indications; operates a comparable single-tenant site-network model with sponsor-direct contracts.

TypeDirect peer
Description

Independent clinical research site network with multiple US locations enrolling in obesity, MASH, CNS, and cardiometabolic trials; closely mirrors IMA's therapeutic breadth and hybrid/DCT positioning.

TypeDirect peer
Description

Multi-specialty Texas-based SMO with a large patient database and broad therapeutic-area coverage; comparable footprint, geography, and sponsor/CRO contract model.

TypeDirect peer
Description

San Antonio-anchored independent research site network; like IMA it operates Texas-based sites and enrolls in obesity, MASH, and CNS trials, making it a close regional peer.

TypeDirect peer
Description

Florida-headquartered SMO network running Phase 1–4 trials across multiple therapeutic areas with a comparable sponsor-direct clinical trial services model.

TypeDirect peer
Description

Independent multi-therapeutic clinical research site organization with a similar mix of CNS, metabolic, and infectious-disease trials for pharma sponsors.

TypeBroad incumbent
Description

Global CRO with embedded site-network capabilities serving the same large-pharma sponsors as IMA; not a head-to-head competitor in niche independent-site deals but competes at the enterprise level.

TypeBroad incumbent
Description

Large CRO offering site management and DCT solutions to pharma/biotech sponsors; competing at the top of the market for multi-region Phase 2–4 contracts.

TypeEmerging player
Description

DCT-native platform that enables fully decentralized trials; overlapping with IMA's decentralized trial offering but reaching patients via telehealth rather than physical sites.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diagnostics Research Group

Clinical Research Servicesdxrg.com

IMA Clinical Research (Diagnostics Research Group) is a US-based clinical trial site network operating 15+ satellite sites across 10 states with a 400K+ patient database, providing site-based, hybrid, and decentralized trial services to pharmaceutical sponsors and CROs across therapeutic areas including depression, obesity, MASH, and memory loss.

What Diagnostics Research Group does

IMA Clinical Research Inc., doing business as Diagnostics Research Group and IMA Clinical Research, is a US-based clinical trial site network founded in 2000 and headquartered in Tarrytown, New York. The company operates 15+ satellite clinical trial sites across 10 states supported by 150+ full-service site locations, with a 400K+ patient database and 10K+ unique weekly patient visits. It runs site-based, hybrid, and fully decentralized clinical trials across four core therapeutic areas: depression, obesity, metabolic liver disease (MASH/NASH), and memory loss.

The platform's underlying technology is operational rather than software-centric: flexible patient outreach centers that can be deployed wherever and whenever needed, patient-centric technology supporting remote participation, and a large proprietary patient database enabling efficient enrollment of qualified, diverse participants. The company offers free liver scans and participant compensation for time and travel as patient-side recruitment tools.

Revenue is generated through professional services contracts with pharmaceutical sponsors and Contract Research Organizations (CROs), structured as per-enrolled-participant compensation with additional payments for specific trial milestones and procedures. The company sells to two customer segments: pharmaceutical sponsors and CROs (the primary enterprise revenue source) and patients (a recruitment channel, not a revenue stream). Go-to-market combines direct enterprise field sales with sponsor-facing thought leadership (webinars, ACRP conference participation, knowledge center content) and patient-facing community outreach (referral programs, social media, phone-based outreach centers).

Diagnostics Research Group firmographics

Firmographics
Name
Diagnostics Research Group
Legal name
IMA Clinical Research Inc.
Website
https://dxrg.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
IMA Clinical Research (Diagnostics Research Group) is a US-based clinical trial site network operating 15+ satellite sites across 10 states with a 400K+ patient database, providing site-based, hybrid, and decentralized trial services to pharmaceutical sponsors and CROs across therapeutic areas including depression, obesity, MASH, and memory loss.
Ownership category
akta.pro rank

Diagnostics Research Group industry classification

Industry
Product category
Clinical Research Services
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Clinical trial services
  • Site-based trials
  • Decentralized clinical trials
  • Patient recruitment
  • Therapeutic research

Where Diagnostics Research Group is headquartered

Location

Headquarters

HQ city
San Antonio
HQ country
United States
HQ region
North America

Offices15 records

Markets served

Diagnostics Research Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Services Contracts: Revenue generated through contracts with pharmaceutical sponsors and Contract Research Organizations (CROs) for conducting clinical trials. Compensation is provided for each enrolled participant, with additional payments for specific trial milestones and procedures performed.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Diagnostics Research Group product offering

Product offering

Core offering

Diagnostics Research Group operates the IMA Clinical Research Network, a flexible clinical trial network that conducts site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs across multiple therapeutic areas including depression, obesity, MASH (metabolic liver disease), and memory loss. The network spans 15+ satellite sites and 150+ total locations in the U.S., supported by a 400K+ patient database with 10K+ unique weekly visits and deployable patient outreach centers.

Product overview

IMA Clinical Research operates a flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials. The network includes full-service clinical trial sites and 15+ nationwide satellite sites with over 10,000 unique weekly visits and access to 400K+ patient database. The platform provides patient-centric technology supporting flexible trial models with deployable patient outreach centers. Therapeutic areas include depression, obesity, liver/MASH, and memory loss clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • IMA Clinical Research Network Flexible clinical trial network offering site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs, comprising full-service sites and 15+ nationwide satellite sites with access to a 400K+ patient database.
  • Site-Based Clinical Trials Traditional in-person clinical trial conduct at full-service clinical trial sites located across multiple states including Arizona, Florida, Illinois, Louisiana, North Carolina, New Jersey, New Mexico, Nevada, New York, and Texas.
  • Hybrid Clinical Trials Combination of site-based and remote participation options, allowing flexible trial conduct with patient outreach centers set up wherever and whenever needed.
  • Fully Decentralized Clinical Trials Remote clinical trial participation options enabled through patient-centric technology, reaching patients regardless of geographic location.
  • Patient Outreach Centers Flexible patient outreach centers deployed wherever and whenever needed to support clinical trial recruitment and expand access to participants across the United States.
  • Depression Clinical Trials Clinical trials for depression currently enrolling patients in Hickory NC, Monroe LA, Albuquerque NM, Phoenix AZ, and Las Vegas NV, with compensation offered to participants for time and travel.
  • Obesity Clinical Trials Clinical trials for obesity enrolling in Warren NJ, St. Petersburg FL, Austin TX, San Antonio TX, Lenoir NC, and Monroe LA, with compensation offered for time and travel.
  • Liver/MASH Clinical Trials Clinical trials for metabolic-associated steatohepatitis (MASH) with free liver scans for individuals with BMI over 27, enrolling in Austin TX, San Antonio TX, Warren NJ, New York City NY, and Westchester NY.
  • Memory Loss Clinical Trials Clinical trials for memory loss enrolling adults 55 and older with compensation offered for time and travel, currently enrolling in Albuquerque NM and San Antonio TX.

Quantifiable outcome

  • 400K+ patient database with 10K+ unique weekly visits
  • +1 more outcomes

Companies that use Diagnostics Research Group

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Diagnostics Research Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Diagnostics Research Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • ACRP (Association of Clinical Research Professionals)minorStrategic or Co-development PartnerProfessional association for clinical research professionals. IMA Clinical Research staff actively participate in ACRP events and conferences (e.g., ACRP 2026), demonstrating ongoing professional relationship and industry engagement.
  • AMRC (Albuquerque Medical Research Center)minorStrategic or Co-development PartnerAMRC is listed as an affiliated organization, with the Albuquerque Neurosciences site operating under this partnership. Represents strategic alignment in the clinical research network.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Diagnostics Research Group competitors and assessment

Company assessment

Direct peers

  • Velocity Clinical Research: National multi-therapeutic clinical trial site network offering site-based, hybrid, and DCT options to sponsors/CROs; directly comparable to IMA in model, therapeutic areas, and customer base.
  • CenExel Clinical Research: Multi-site SMO focused on specialty Phase 2–4 trials in CNS, metabolic, pain, and other indications; operates a comparable single-tenant site-network model with sponsor-direct contracts.
  • Flourish Research: Independent clinical research site network with multiple US locations enrolling in obesity, MASH, CNS, and cardiometabolic trials; closely mirrors IMA's therapeutic breadth and hybrid/DCT positioning.
  • DM Clinical Research: Multi-specialty Texas-based SMO with a large patient database and broad therapeutic-area coverage; comparable footprint, geography, and sponsor/CRO contract model.
  • Clinical Trials of Texas: San Antonio-anchored independent research site network; like IMA it operates Texas-based sites and enrolls in obesity, MASH, and CNS trials, making it a close regional peer.
  • Accel Research Sites: Florida-headquartered SMO network running Phase 1–4 trials across multiple therapeutic areas with a comparable sponsor-direct clinical trial services model.
  • Benchmark Research: Independent multi-therapeutic clinical research site organization with a similar mix of CNS, metabolic, and infectious-disease trials for pharma sponsors.

Broad incumbents

  • IQVIA (Site Management): Global CRO with embedded site-network capabilities serving the same large-pharma sponsors as IMA; not a head-to-head competitor in niche independent-site deals but competes at the enterprise level.
  • Thermo Fisher Scientific (PPD): Large CRO offering site management and DCT solutions to pharma/biotech sponsors; competing at the top of the market for multi-region Phase 2–4 contracts.

Emerging players

  • Science 37: DCT-native platform that enables fully decentralized trials; overlapping with IMA's decentralized trial offering but reaching patients via telehealth rather than physical sites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Diagnostics Research Group social profiles

Digital presence

Diagnostics Research Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diagnostics Research Group leadership team

Management profile

Number of profiles

Profiles1 record

Diagnostics Research Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diagnostics Research Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnostics Research Group

What does Diagnostics Research Group do?

Diagnostics Research Group operates the IMA Clinical Research Network, a flexible clinical trial network that conducts site-based, hybrid, and fully decentralized clinical trials for pharmaceutical sponsors and CROs across multiple therapeutic areas including depression, obesity, MASH (metabolic liver disease), and memory loss. The network spans 15+ satellite sites and 150+ total locations in the U.S., supported by a 400K+ patient database with 10K+ unique weekly visits and deployable patient outreach centers.

Is Diagnostics Research Group a public or private company?

Diagnostics Research Group is a private company. It is classified as unknown and is currently operating.

When was Diagnostics Research Group founded?

Diagnostics Research Group was founded in 2000. It employs 11 to 50 people.

Where is Diagnostics Research Group based?

Diagnostics Research Group is headquartered in San Antonio, United States, in the North America region.

How does Diagnostics Research Group make money?

One revenue line is on record: clinical Trial Services Contracts.

Who are Diagnostics Research Group's main competitors?

Direct peers on record are Velocity Clinical Research, CenExel Clinical Research, Flourish Research, DM Clinical Research, Clinical Trials of Texas, Accel Research Sites and Benchmark Research. Broad incumbents are IQVIA (Site Management) and Thermo Fisher Scientific (PPD). Science 37 is listed as an emerging player.

Does Diagnostics Research Group have an API?

No public API is recorded for Diagnostics Research Group.

What industry is Diagnostics Research Group in?

Diagnostics Research Group's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 6215 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales